A detailed history of Deutsche Bank Ag\ transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 54,329 shares of OLMA stock, worth $247,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,329
Previous 39,331 38.13%
Holding current value
$247,196
Previous $229,000 10.92%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$3.76 - $6.39 $56,392 - $95,837
14,998 Added 38.13%
54,329 $204,000
Q4 2024

Feb 14, 2025

BUY
$5.61 - $12.72 $68,436 - $155,171
12,199 Added 44.96%
39,331 $229,000
Q3 2024

Jun 26, 2025

SELL
$10.41 - $16.46 $283,120 - $447,662
-27,197 Reduced 50.06%
27,132 $323,000
Q3 2024

Nov 13, 2024

SELL
$10.41 - $16.46 $2.36 Million - $3.73 Million
-226,742 Reduced 89.31%
27,132 $323,000
Q2 2024

Jun 12, 2025

BUY
$8.73 - $13.99 $1.74 Million - $2.79 Million
199,545 Added 367.29%
253,874 $2.75 Million
Q2 2024

Aug 14, 2024

BUY
$8.73 - $13.99 $42,288 - $67,767
4,844 Added 1.95%
253,874 $2.75 Million
Q1 2024

Jun 02, 2025

BUY
$10.95 - $16.62 $2.13 Million - $3.24 Million
194,701 Added 358.37%
249,030 $2.82 Million
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $4,040 - $6,132
369 Added 0.15%
249,030 $2.82 Million
Q4 2023

Feb 14, 2024

BUY
$10.53 - $17.14 $2.47 Million - $4.01 Million
234,143 Added 1612.78%
248,661 $3.49 Million
Q3 2023

Nov 09, 2023

SELL
$8.19 - $12.98 $1.92 Million - $3.04 Million
-234,177 Reduced 94.16%
14,518 $179,000
Q2 2023

Aug 14, 2023

SELL
$3.22 - $9.65 $19,394 - $58,121
-6,023 Reduced 2.36%
248,695 $2.25 Million
Q1 2023

May 15, 2023

SELL
$2.55 - $4.97 $514,967 - $1 Million
-201,948 Reduced 44.22%
254,718 $883,000
Q2 2022

Aug 11, 2022

BUY
$2.04 - $4.61 $816,467 - $1.85 Million
400,229 Added 709.16%
456,666 $1.86 Million
Q1 2022

May 13, 2022

SELL
$3.89 - $9.43 $197,331 - $478,365
-50,728 Reduced 47.34%
56,437 $240,000
Q4 2021

Feb 11, 2022

BUY
$8.75 - $30.71 $8,575 - $30,095
980 Added 0.92%
107,165 $1 Million
Q3 2021

Nov 04, 2021

BUY
$22.96 - $30.13 $162,878 - $213,742
7,094 Added 7.16%
106,185 $2.93 Million
Q2 2021

Aug 11, 2021

BUY
$21.15 - $36.14 $1.81 Million - $3.09 Million
85,615 Added 635.31%
99,091 $2.77 Million
Q1 2021

May 13, 2021

BUY
$27.81 - $53.64 $374,767 - $722,852
13,476 New
13,476 $447,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $184M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.